Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 50% during trading on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Price Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm’s fifty day moving average price is C$0.07 and its 200 day moving average price is C$0.06. The firm has a market capitalization of C$14.64 million, a PE ratio of -10.50 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Why is the Ex-Dividend Date Significant to Investors?
- Why Aehr Test Systems Could Be a Hidden AI Semiconductor Winner
- What Are Trending Stocks? Trending Stocks Explained
- Get Ahead of the January Effect With These 2 Fintech Stocks
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
